Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Therapies for Resistant Focal Segmental Glomerulosclerosis

NCT00814255 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT00814255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00814255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Therapies for Resistant Focal Segmental Glomerulosclerosis
Lead sponsor
NYU Langone Health
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2008
Completion date
February 28, 2014
Enrollment
32 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

focal segmental glomerulosclerosis